Russia’s coronavirus ‘vaccine’ announced – but don’t dismiss it just yet, writes BEN SPENCER 

Russia’s coronavirus ‘vaccine’ announced by Vladimir Putin is shrouded in secrecy – but don’t dismiss it just yet, writes BEN SPENCER By Ben Spencer for the Daily Mail Published: 23:24 BST, 11 August 2020 | Updated: 00:21 BST, 12 August 2020 Russia’s claims to have created the world’s first coronavirus vaccine should not be dismissed … Read more

Britain’s youngest Covid-19 survivor: Parents’ joy as Emmanuel wins a 47-day fight with the virus

Britain’s youngest Covid-19 survivor: Parents’ joy as three-months premature Emmanuel wins a 47-day fight with the virus before he was even due to be born Three-month-old Emmanuel Boateng is believed to be UK’s youngest survivor He spent nearly two months in hospital on a ventilator to help him breathe  Emmanuel was born at just 27 weeks and taken to … Read more

How a test can diagnose coronavirus in just 30 minutes in technique previously used to detect Ebola

Test can diagnose coronavirus in just 30 minutes by analysing urine, blood or saliva samples is developed by scientists Method known as reverse transcription loop-mediated isothermal amplification Has been previously used to detect viruses such as Zika and Ebola  Method involves looking for genetic material, or RNA, of the coronavirus in the test samples  Here’s how … Read more

Coronavirus: Remdesivir users 65% more likely to improve

Coronavirus patients in hospital may be 65 per cent more likely to see their condition improve if they are given the antiviral drug remdesivir, its manufacturer claims. Gilead Sciences, a California-based company that developed the drug in a bid to tackle Ebola, today reported the promising results for Covid-19 patients. After 11 days patients taking … Read more

NHS gets green light to treat coronavirus patients with Ebola drug remdesivir

Health chiefs grant NHS emergency access to give severely ill Covid-19 patients promising Ebola drug remdesivir By Sam Blanchard Senior Health Reporter For Mailonline Published: 11:04 BST, 26 May 2020 | Updated: 11:07 BST, 26 May 2020 Coronavirus patients in Britain can now be treated with remdesivir, the Ebola drug which has shown promise in … Read more

Mother whose son was treated for Covid-19 with Ebola drug reveals moment she thought she’d lost him

A 14-year-old boy left critically ill by the coronavirus has survived his ordeal after being given the Ebola drug remdesivir, his family have revealed. Jacob Tayel, from Ipswich, fell ill with what his mother assumed was a chest infection in March, and his 11-year-old brother, Isaac, was ill at the same time. Dianne, their mother, … Read more

Expert calls for protocols to keep alien viruses from infecting Earth after humans visit Mars

It may sound like a plot from a science fiction film, but NASA and scientists are concerned about alien viruses contaminating Earth.  As the first humans prepare for the Mars mission, experts warn that protocols are necessary to keep extraterrestrial pollutants from hitchhiking on space ships and astronauts when returning home from the Red Planet. Stanford … Read more

Gilead looks for global partners to help make its experimental coronavirus drug remdesivir

Gilead Sciences Inc says it is planning to work with international partners to boost production of its experimental coronavirus drug remdesivir. On Friday, the US Food and Drug Administration (FDA) issued emergency use authorization for the medication made by the California-based company.  Remdesivir, which was originally developed as an Ebola drug, is given to hospitalized … Read more

Remdesivir trial data ‘offers hope,’ says Gilead CEO

On the heels of an early announcement that coronavirus patients given Gilead’s Ebola drug remdesivir fared better than those who didn’t get the treatment, the company’s CEO, Daniel O’Day, deemed the results a cause for ‘hope at a time when it is badly needed,’ in an open letter obtained by Fox News.   ‘Positive data’ from … Read more

Gilead can make enough remdesivir to treat ‘several million’ next year

Gilead Sciences said that it has capacity to make enough doses of its drug remdesivir for ‘several million treatment courses’ next year in a Thursday press release announcing its first quarter earnings.   ‘As Gilead continues to work with international partners to expand production, Gilead announced it anticipates more than one million treatment courses will be … Read more